Randomized, Double-blind, Placebo-controlled Trial, to Evaluate the Safety and Immunogenicity of Orally Administered, Killed, Bivalent Whole-cell, Cholera Vaccine, ShanChol in Bangladeshi Adults and Children.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2014
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Adverse reactions
- 29 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Dec 2012 Planned End Date changed from 1 Nov 2010 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 03 Dec 2012 Status changed from completed to recruiting as reported by ClinicalTrials.gov.